ERBB2 and non-small cell lung carcinoma: Therefore, we have performed a retrospective study to elucidate the prevalence of HER2 alterations and the characteristics of NSCLC patients with these alterations, based on diagnostic next-generation sequencing (NGS) performed at a tertiary private referral medical center in Malaysia.